BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34048919)

  • 1. Aortic Pulsatility Index: A Novel Hemodynamic Variable for Evaluation of Decompensated Heart Failure.
    Belkin MN; Kalantari S; Kanelidis AJ; Miller T; Smith BA; Besser SA; Tehrani D; Chung BB; Nguyen A; Sarswat N; Blair JEA; Burkhoff D; Sayer G; Pinney SP; Uriel N; Kim G; Grinstein J
    J Card Fail; 2021 Oct; 27(10):1045-1052. PubMed ID: 34048919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aortic pulsatility index predicts clinical outcomes in heart failure: a sub-analysis of the ESCAPE trial.
    Belkin MN; Alenghat FJ; Besser SA; Nguyen AB; Chung BB; Smith BA; Kalantari S; Sarswat N; Blair JEA; Kim GH; Pinney SP; Grinstein J
    ESC Heart Fail; 2021 Apr; 8(2):1522-1530. PubMed ID: 33595923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PREDICT HF: Risk stratification in advanced heart failure using novel hemodynamic parameters.
    Cyrille-Superville N; Rao SD; Feliberti JP; Patel PA; Swayampakala K; Sinha SS; Jeng EI; Goswami RM; Snipelisky DF; Carroll AM; Najjar SS; Belkin M; Grinstein J;
    Clin Cardiol; 2024 Jun; 47(6):e24277. PubMed ID: 38838029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decoupling Between Diastolic Pulmonary Artery Pressure and Pulmonary Capillary Wedge Pressure as a Prognostic Factor After Continuous Flow Ventricular Assist Device Implantation.
    Imamura T; Chung B; Nguyen A; Rodgers D; Sayer G; Adatya S; Sarswat N; Kim G; Raikhelkar J; Ota T; Song T; Juricek C; Kagan V; Jeevanandam V; Mehra M; Burkhoff D; Uriel N
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Impact of Pulmonary Artery Pulsatility Index (PAPi) in Patients With Advanced Heart Failure: Insights From the ESCAPE Trial.
    Kochav SM; Flores RJ; Truby LK; Topkara VK
    J Card Fail; 2018 Jul; 24(7):453-459. PubMed ID: 29597051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-Aortic Balloon Counterpulsation in Patients With Chronic Heart Failure and Cardiogenic Shock: Clinical Response and Predictors of Stabilization.
    Sintek MA; Gdowski M; Lindman BR; Nassif M; Lavine KJ; Novak E; Bach RG; Silvestry SC; Mann DL; Joseph SM
    J Card Fail; 2015 Nov; 21(11):868-76. PubMed ID: 26164215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute Biventricular Mechanical Circulatory Support for Cardiogenic Shock.
    Kuchibhotla S; Esposito ML; Breton C; Pedicini R; Mullin A; O'Kelly R; Anderson M; Morris DL; Batsides G; Ramzy D; Grise M; Pham DT; Kapur NK
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29054842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and hemodynamic effects of intra-aortic balloon pump therapy in chronic heart failure patients with cardiogenic shock.
    Fried JA; Nair A; Takeda K; Clerkin K; Topkara VK; Masoumi A; Yuzefpolskaya M; Takayama H; Naka Y; Burkhoff D; Kirtane A; Karmpaliotis D; Moses J; Colombo PC; Garan AR
    J Heart Lung Transplant; 2018 Nov; 37(11):1313-1321. PubMed ID: 29678608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using pulsatility responses to breath-hold maneuvers to predict readmission rates in continuous-flow left ventricular assist device patients.
    Krishnaswamy RJ; Robson D; Gunawan A; Ramanayake A; Barua S; Jain P; Adji A; Macdonald PS; Hayward CS; Muthiah K
    Artif Organs; 2024 Jan; 48(1):70-82. PubMed ID: 37819003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
    Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced hemodynamics for prognostication in heart failure: the pursuit of the patient-specific tipping point.
    Grinstein J
    Front Cardiovasc Med; 2024; 11():1365696. PubMed ID: 38500751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aortic Pulsatility Index: A New Haemodynamic Measure with Prognostic Value in Advanced Heart Failure.
    Deis T; Rossing K; Gustafsson F
    Card Fail Rev; 2022 Jan; 8():e18. PubMed ID: 35620383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordance between lactic acidemia and hemodynamics in patients with advanced heart failure.
    Narang N; Dela Cruz M; Imamura T; Chung B; Nguyen AB; Holzhauser L; Smith BA; Kalantari S; Raikhelkar J; Sarswat N; Kim GH; Jeevanandam V; Burkhoff D; Sayer G; Uriel N
    Clin Cardiol; 2021 May; 44(5):636-645. PubMed ID: 33734459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary artery pulsatility index predicts prolonged inotrope/pulmonary vasodilator use after implantation of continuous flow left ventricular assist device.
    Aggarwal V; Tume SC; Rodriguez M; Adachi I; Cabrera AG; Tunuguntla H; Qureshi AM
    Congenit Heart Dis; 2019 Nov; 14(6):1130-1137. PubMed ID: 31802608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative Hemodynamic and Echocardiographic Measurements Associated With Severe Right Ventricular Failure After Left Ventricular Assist Device Implantation.
    Gudejko MD; Gebhardt BR; Zahedi F; Jain A; Breeze JL; Lawrence MR; Shernan SK; Kapur NK; Kiernan MS; Couper G; Cobey FC
    Anesth Analg; 2019 Jan; 128(1):25-32. PubMed ID: 29878942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decoupling Between Diastolic Pulmonary Artery and Pulmonary Capillary Wedge Pressures Is Associated With Right Ventricular Dysfunction and Hemocompatibility-Related Adverse Events in Patients With Left Ventricular Assist Devices.
    Imamura T; Narang N; Kim G; Raikhelkar J; Chung B; Nguyen A; Holzhauser L; Rodgers D; Kalantari S; Smith B; Ota T; Song T; Juricek C; Burkhoff D; Jeevanandam V; Sayer G; Uriel N
    J Am Heart Assoc; 2020 Apr; 9(7):e014801. PubMed ID: 32223394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary perfusion pressure is associated with adverse outcomes in advanced heart failure.
    Mazimba S; Jeukeng C; Ondigi O; Mwansa H; Johnson AE; Elumogo C; Breathett K; Kwon Y; Mubanga M; Mwansa V; Baldeo C; Ibrahim S; Selinski C; Mehta N; Bilchick K
    Perfusion; 2023 Oct; 38(7):1492-1500. PubMed ID: 35947883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Liver Dysfunction After Left Ventricular Assist Device Implantation.
    Rosenbaum AN; Ternus BW; Pahwa S; Stulak JM; Clavell AL; Schettle SD; Behfar A; Jentzer JC
    Ann Thorac Surg; 2021 Jun; 111(6):1961-1967. PubMed ID: 33058819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical presentation and outcomes in women and men with advanced heart failure.
    Vishram-Nielsen JKK; Deis T; Rossing K; Wolsk E; Alba AC; Gustafsson F
    Scand Cardiovasc J; 2020 Dec; 54(6):361-368. PubMed ID: 32666856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricle assist device pulsatility index at the time of implantation is associated with follow-up pulmonary hemodynamics.
    Schaefer JJ; Sajgalik P; Kushwaha SS; Olson LJ; Stulak JM; Johnson BD; Schirger JA
    Int J Artif Organs; 2020 Jul; 43(7):452-460. PubMed ID: 31984834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.